News | November 29, 2006

Device Near Carotids May Lower Blood Pressure

An implantable technology to control high blood pressure in patients not responding to available medicines has demonstrated initial favorable results in a study conducted at the University Hospital Berne in Switzerland. Developed by Minneapolis-based CVRx in 2002 and entering a clinical trial in the U.S., the tiny device - called the Rheos system - was first implanted in 11 patients undergoing surgery for carotid stenosis. Dr. Jurg Schmidli and colleagues placed electrodes outside the carotid wall and applied electrical stimulation. The result, reports Newsday.com, was a swift drop in blood pressure. Stimulating the carotid sinus sends messages to baroreceptors in the brain that control blood pressure. The study was expanded into a multicentered trial of 45 patients, 31 of whom have had surgery to place electrodes outside the carotid and to place an internal pulse generator into the chest wall. Dr. Schmidli operated on six of these patients. He has reported that the first 16 patients experienced an average drop of 29 millimeters of mercury. "By comparison, if a drug reduced blood pressure by 9 millimeters it is considered major,� Dr. Schmidli said. "It is promising." "This has tremendous potential," said Dr. Frank Veith, a professor of surgery at New York University School of Medicine who runs an annual scientific symposium for vascular surgeons in Manhattan. The Veith Symposium, now in its 33rd year, is attended by hundreds of surgeons worldwide. "It's early, but ultimately I think it may work," Veith said of the new device.

Related Content

The FDA is concerned about cybersecurity of ICDs and cyber security of other medical devices.
Feature | Cybersecurity| August 16, 2017 | Dave Fornell
There is growing concern among patients and regulators that medical devices, especially implantable electrophysiology
The Vascular Dynamics MobiusHD device enhances the carotid baroreceptors to reduce resistant hypertension.
News | Hypertension| August 15, 2017
Aug. 15, 2017 — The U.S. Food and Drug Administration (FDA) has approved the Vascular Dynamics Inc.
Three New Atrial Fibrillation Studies to Feature HeartLight Endoscopic Ablation System
News | Ablation Systems| August 07, 2017
CardioFocus Inc. announced that its HeartLight Endoscopic Ablation System is being featured in three new major clinical...
Merge Hemo cath lab hemodynamics monitoring system.

Hemodynamic data shown on screens from the Merge Hemo recording system. It is among the newer generation hemodynamic systems for cath labs that are more user friendly and have technologies to speed workflow.

Feature | Hemodynamic Monitoring Systems| August 03, 2017 | Dave Fornell
The current generation of...
Left Atrial Pressure Monitor from Vectorious Medical Technologies Offers New Hope for Heart Failure Patients

On of the top stories in July was the introduction of a left atrial pressure monitor from Vectorious Medical Technologies to prevent heart failure patient hospitalizations or readmissions. Read the article"Left Atrial Pressure Monitor Offers New Hope for Heart Failure Patients."

Feature | August 01, 2017 | Dave Fornell
Aug.
Ohio State Researchers Prove Human Heart's 'Battery' Has Multiple Backups
News | EP Lab| July 27, 2017
July 27, 2017 — There is good news when it comes to the heart’s sinoatrial node (SAN), the body’s natural...
Medtronic Announces First Enrollments in STOP AF First Clinical Trial
News | Ablation Systems| July 24, 2017
Medtronic plc recently announced first enrollments in the STOP AF First clinical trial. The trial will evaluate the...
Biotronik Launches DX Technology for U.S. Heart Failure Patients
News | Cardiac Resynchronization Therapy Devices (CRT)| July 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and availability of the Intica DX and Intica...
Overlay Init